Patient reporting of suspected adverse drug reactions: A review of published literature and international experience

British Journal of Clinical Pharmacology

Volumn 63, Issue 2, 2007, Pages 148-156

  Blenkinsopp, A ^a   Wilkie, P ^b,c,d   Wang, M ^e   Routledge, P A ^f  

^a KEELE UNIVERSITY   (United Kingdom)

^b Academy of Medical Royal Colleges   (United Kingdom)

^c Committee on Safety of Medicines ^*

^d CSM Patient Reporting of ADR Working Group

^e MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY   (United Kingdom)

^f CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Adverse drug reactions (ADRs); Consumers; Patients; Pharmacovigilance; Reporting; Side effects

Indexed keywords

AMOXICILLIN; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CITALOPRAM; COTRIMOXAZOLE; HERBACEOUS AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOTRETINOIN; METHOTREXATE; PAROXETINE; ROFECOXIB; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

AUSTRALIA; CANADA; CAUSAL ATTRIBUTION; CINAHL; DENMARK; DRUG SURVEILLANCE PROGRAM; HEALTH BEHAVIOR; HEALTH CARE QUALITY; HEALTH PRACTITIONER; HUMAN; INFORMATION RETRIEVAL; INTERNET; MEDICAL RESEARCH; MEDLINE; NETHERLANDS; PATIENT ATTITUDE; PATIENT PARTICIPATION; PRESCRIPTION; PRIORITY JOURNAL; PSYCINFO; PUBLISHING; REVIEW; SELF REPORT; SWEDEN; UNITED STATES; UNSPECIFIED SIDE EFFECT;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DRUG MONITORING; DRUG THERAPY; HUMANS; PHARMACEUTICAL PREPARATIONS;

EID: 33846120161     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2006.02746.x     Document Type: Review

References (35)

1. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329: 15-19.
2. Wiffen P, Gill M, Edwards J, Moore A. Adverse drug reactions in hospital patients - a systematic review of the prospective and retrospective studies. Bandolier Extra 2002; June: 1-14. Available at http://www.jr2.ox.ac.uk/ bandolier/Extraforbando/ADRPM.pdf
3. Lazarou J, Pomeranz B, Corey P. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200-5.
4. World Health Organisation. Safety of Medicines - A Guide to Detecting and Reporting of Adverse Drug Reactions. Why Health Professionals Need to Take Action. Geneva: WHO 2002. Available at http://mednet2.who.int/tbs/safety/ esd_safety.pdf (last accessed: 17 February 2006).
5. van Grootheest K, de Graaf L, de Jong-van den Berg L. Consumer adverse drug reaction reporting: a new step in pharmacovigilance? Drug Safety 2003; 26: 211-7.
6. Anonymous. UK call for patient adverse drug reaction reporting. Scrip 2001; 2634: 4.
7. MIND. Seroxat Briefing. May 2003. Available at http://www. mind.org.uk/NR/rdonlyres/B6FA6A72-89F9-454C-9165-B346FD7A2E07/0/ MindSeroxatbriefing.pdf (last accessed: 17 February 2006).
8. Anonymous. Patients able to report ADRs via NHS Direct. Pharm J 2003;270: 608. Available at http://www.pjonline.com/Editorial/ 20030503/news/nhsdirect. html (last accessed: 17 February 2006).
9. Lammy D. Supplementary Evidence to the Select Committee on Health. May 2003. Available at http://www.publications. parliament.uk/pa/cm200203/cmselect/ cmhealth/697/3051508.htm (last accessed: 17 February 2006).
10. Independent Steering Committee. Report of an Independent Review of Access to the Yellow Card Scheme. London: The Stationery Office 2004.
11. Danish Medicines Agency. One Year with ADR Consumer Reports. October 2004. Available at http://www.dkma.dk/1024/visUKLSArtikel.asp?artikelID= 4710 (last accessed: 17 February 2006).
12. van Grootheest AC, Passier JL, van Puijenbrock EP. Direct reporting of side effects by the patient: favourable experience in the first year. Ned Tijdschr Geneeskd 2005; 149: 529-33.
13. van Grootheest AC, de Jong-van den Berg L. Review: Patients' role in reporting adverse drug reactions. Exp Opin Drug Saf 2004; 3: 363-8. Available at http://www.lareb.nl/documents/ExpOp2004_1485.pdf (last accessed: 17 February 2006).
14. Meldpunt Medicijnen. Summary of First Year's Reports. English summary available at http://www.meldpuntmedicijnen.nl/mm/mm/pages/frontpageread/ bgidfjca?id=0x6d6d3a33373840 636f6d2e7669616465736b2e776562736974652e50616765 (last accessed: 25 May 2006).
15. KILEN. Consumer Reports on Medicines (CRM) - Consensus Document. 2000. Available at http://www.kilen.org/indexe.htm (last accessed: 17 February 2006).
16. Health Action International Europe. Patient Reporting of Adverse Drug Reactions - Seminar Report. 2005. Available at http://www.haiweb.org/docs2005/ final_report.doc (last accessed: 17 February 2006).
17. Graham JD. Magic number. The Australian Health Consumer (2) 2003-4; 32-4.
18. Australian Council for Safety and Quality in Health Care. Partnerships for Health in Action: Promoting Consumer and Community Involvement in Health Care Improvement. 2005. Available at http://www.safetyandquality.org/ consumrept0705_2.pdf (last accessed: 17 February 2006).
19. Safety and Quality Council of Australia. Consumer Update. November 2004. Available at http://www.safetyandquality.org/newsnov04.pdf (last accessed: 17 February 2006).
20. Herxheimer A, Mintzes B. Antidepressants and adverse effects in young patients: uncovering the evidence. CMAJ 2004; 170: 487-9. Available at http://www.cmaj.ca/cgi/content/full/170/12/1771-b (last accessed: 17 February 2006).
21. Vastag B. Consumer groups look to improve adverse event reporting systems. J Nat Cancer Inst 2005; 97: 1804-5.
22. Brown B. Opening the Medicines Cabinet. First report on health aspects of prescription drugs. Report of the Standing Committee on Health 2004, House of Commons, Canada. Available at http://www.healthcoalition.ca/healrp01-e.pdf (last accessed: 17 February 2006).
23. DeWitt JE, Sorofman BA. A model for understanding patient attribution of ADRs. Drug Information J 1999; 33: 907-20.
24. Jarernsiripornkul N, Krska J, Capps PAG, Richards RM, Lee A. Patient reporting of potential adverse drug reactions: a methodological study. Br J Clin Pharmacol 2002; 53: 318-25.
25. Jarernsiripornkul N, Krska J, Richards RM, Capps PAG. Patient reporting of adverse drug reactions: useful information for pain management? Eur J Pain 2003; 7: 219-24.
26. Mitchell AS, Henry DA, Sanson-Fisher R, O'Connell DL. Patients as a direct source of information on adverse drug reactions. BMJ 1988; 297: 891-3.
27. Somers A, Petrovic M, Robays H, Bogaert M. Reporting adverse drug reactions on a geriatric ward: a pilot project. Eur J Clin Pharmacol 2003; 58: 707-14.
28. Aspinall MB, Whittle J, Aspinall SL, Maher RL, Good CB. Improving Adverse-drug-reaction reporting in ambulatory care clinics at a Veterans Affairs Hospital. Am J Health Syst Pharm 2002; 59: 841-5.
29. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45.
30. Medawar C, Herxheimer A. A comparison of adverse drug reaction reports from professionals and users, relating to risk of dependence and suicidal behaviour with paroxetine. Int J Risk Saf Med 2003; 16: 5-19. Available at http://www.socialaudit.org.uk/YELLOW%20CARD%20REVIEW.pdf (last accessed: 17 February 2006).
31. Medawar C, Herxheimer A, Bell A, Jofre S. Paroxetine, Panorama and user reporting of ADRs: consumer intelligence matters in clinical practice and post-marketing drug surveillance. Int J Risk Saf Med 2002; 15: 161-9. Available at http://www.socialaudit.org.uk/IJRSM-161-169.pdf (last accessed: 17 February 2006).
32. Royal College of General Parctitioners. Seven Days. 13-19 February 2006. Available at http://dev03.rcgp.org.uk/information/ publications/sevendays/2006/ FEB19.asp (last accessed: 10 April 2006).
33. Roughead E. Managing ADRs: time to get serious. Med J Aust 2005; 182: 264-5.
34. European Medicines Evaluation Agency/Committee on Proprietary Medicinal Products (EMEA/CPMP) Working Group with Patient Organisations. Recommendations for Action. 2004 Available at http://www.emea.eu.International/pdfs/human/ patientgroup/581904.pdf (last accessed: 12 April 2006).
35. Evaluation of Patient Reporting to the Yellow Card System. Available at http://pcpoh.bham.ac.uk/publichealth/nccrm/PDFs %20and%20documents/ invitations_to_tender/RM05_JH30_Patient_reporting_to_YC.pdf (last accessed: 25 May 2006).